CORTANCYL 20 mg, comprimé sécable, Placebo of CORTANCYL 20 mg
P160913
Phase 3 small_molecule active
Quick answer
CORTANCYL 20 mg, comprimé sécable, Placebo of CORTANCYL 20 mg for Adults patients with isolated acute urticaria presenting to the emergency department is a Phase 3 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pari Pharma GmbH
- Indication
- Adults patients with isolated acute urticaria presenting to the emergency department
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active